Antiviral Drugs Market: Introduction
Antiviral agents used to control or cure viral infections. Majority of these drugs are used for specific viral infections, while a few (broad-spectrum antiviral drugs) are effective against a wide range of viruses. Entry of new viruses and thereby high research and development activities in the field, approval of new drugs, and collaborations between market players and governments are likely to accelerate the market growth. Increase in the number of cases of viral infections such as coronavirus, influenza, hepatitis, and Human Immunodeficiency Virus (HIV) is a major driver for the market growth. Furthermore, increasing awareness and thereby diagnosis rate in current pandemic condition is expected to boost the demand of antiviral drugs.
Antiviral Drugs Market: Factors Driving Growth
Rising viral infections across the globe is expected to boost the market growth. For instance, starting from January 2018, Nigeria experienced unusually large outbreak of haemorrhagic fever caused by Lassa virus. Later, Indian state Kerala experienced an outbreak of rare Nipah virus, which causes severe inflammation of the brain. In late 2017, Brazil’s highly populated area experienced viral yellow fever outbreak. Currently, Corona virus has impacted the life of people across the globe.
With the presence of large patient population, a lot of new opportunities are available for new entrants as well as for existing players. As there are many international companies already present in the antiviral drugs market, a detailed competitive knowledge of the competitors will be crucial for the success of company. The report provides in depth competitive analysis high lighting sources of competitive advantage present in the market.
In global antiviral drugs market, with outbreak of Corona virus and approval of remdesivir, nucleotide polymerase inhibitor segment is expected to grow at significant rate during the forecast period. Local presence of market players, recent approvals, high diagnosis rate, and supportive insurance policies are some of the factors responsible for the dominance of North America and Europe in the market. Asia Pacific is expected to observe the fastest growth during the forecast period due to presence of large patient pool, increasing awareness about viral infection, and investment of several international players in the region.
The report is titled ‘Antiviral Market by Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others), Type (Generic, Branded), Application (HIV, Hepatitis, Influenza, Herpes, Others), and Region - Global Forecasts 2017 to 2027' and was published in November 2020.
Market Segmentation and Scope of the ‘Antiviral Drugs Market’ report
This report aims to identify and analyse antiviral drugs based on their mechanism of action, application, and type. The report has segmented the global antiviral drugs market as follows:
Antiviral Drugs Market by Mechanism of Action
The antiviral drugs market has been segmented in terms of mechanism of action as Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others
Antiviral Drugs Market by Type
The antiviral drugs market has been segmented in terms of type as Generic and Branded.
Antiviral Drugs Market by Application
The antiviral drugs market has been segmented in terms of application as HIV, Hepatitis, Influenza, Herpes, and Others
Antiviral Drugs Market by Geography
The antiviral drugs market has been segmented in terms of geography as North America, Europe, Asia Pacific, South America, and ROW. Major countries have been analysed in each of these geographies
Key Companies Analysed by this report include F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Abbott Laboratories, Bristol-Myers-Squibb, Gilead Sciences, AstraZeneca plc., Schering-Plough Corporation, AbbVie Inc., Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. amongst others
The unique insights and benefits provided by this report also include the following:
· In-depth value chain analysis
· Opportunity mapping
· Sector snapshot
· Technology landscape
· Regulatory scenario
· Patent trends
· Market trends
· Covid-19 impact analysis
· Raw material supply analysis
· Pricing trends
· Sustainability trends and environmental concerns
· Critical Success Factors
· Sources of competitive advantage
· Customer preferences
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market date in the form tables and charts for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides company profiles for each of its sub-segments.
Read More- https://www.alltheresearch.com/report/691/antiviral-drugs-marke
Home / Pharmaceutics / Antiviral Drugs Market
+1 (407) 768-2028
Log in / Register
Date : Jun 2021
Report ID : 691
Category : Pharmaceutics
Antiviral Drugs Market Report Overview
The global antiviral drugs market is projected to grow at a CAGR of 3.8% to reach USD $50 billion by 2027 from $39
billion in 2020. Rising awareness about viral infections, availability of diagnostics, presence of several drugs, and
significant strategic initiatives by industry players has contributed to the growth of this market.
The research report categorizes the antiviral drugs market to forecasts the revenues and analyses the trends in each
of the following below mentioned market segments.
By Mechanism of Action
Nucleotide Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Antiviral Drugs Market By Type:
Antiviral Drugs Market by Mechanism of Action (Nucleotide Polymerase
Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others),
Type (Branded and Generic), Application (HIV, Hepatitis, Influenza, Herpes,
Others) and Region - Global Forecasts 2017 to 2027
Table of Contents
Ask for Customization
Why Choose AllTheResearch?
• Monthly market updates for 6
• Online access of
• Options to buy sections of
• Critically analysed research on
“Quadrant Positioning” of your
• Syndicated report along with a
supplementary report with
• Get profiled in the reports.
Expanding your visibility
across our network of readers
• We provide local market data
in local language on request
• A complementary co-branded
• Flat consulting fee based
exclusive studies. Consult at
the price of syndicate
• Access to expert team for free